Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis

Thrombosis Research

Volumn 121, Issue 3, 2007, Pages 301-307

  Libourel, Eduard J ^a   Kate, Min Ki ten ^a   Brouwer, Jan Leendert P ^a   Veeger, Nic J G M ^a   van der Meer, Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cerebral sinus thrombosis; Cerebral venous thrombosis; Risk factors; Thrombophilia; Venous thromboembolism

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; CONTROL GROUP; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE COURSE; FEMALE; FERTILE PERIOD; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL CONTRACEPTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CEREBRAL VEINS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 37749024040     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.03.029     Document Type: Article

References (22)

1. Ameri A., and Bousser M.G. Cerebral venous thrombosis. Neurol Clin 10 (1992) 87-111
2. Daif A., Awada A., al-Rajeh S., Abduljabbar M., al Tahan A.R., Obeid T., et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke 26 (1995) 1193-1195
3. Cantu C., and Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 24 (1993) 1880-1884
4. Ferro J.M., Canhào P., Stam J., Bousser M.G., Barinagarrementeria F., and ISCVT investigators. Prognosis of cerebral vein and dural sinus thrombosis. Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35 (2004) 664-670
5. Bousser M.G., Chiras J., Bories J., and Castaigne P. Cerebral venous thrombosis-a review of 38 cases. Stroke 16 (1985) 199-213
6. Preter M., Tzourio C., Ameri A., and Bousser M.G. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 27 (1996) 243-246
7. De Bruijn S.F.T.M., Budde M., Teunisse S., Haan R.J., and Stam J. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology 54 (2000) 1687-1689
8. Baumgartner R.W., Studer A., Arnold M., and Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry 74 (2003) 459-461
9. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 352 (2005) 1791-1798
10. Dentali F., Crowther M., and Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 107 (2006) 2766-2773
11. Nordström M., Lindblad B., Bergqvist D., and Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232 (1992) 155-160
12. Frezzato M., Tosetto A., and Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 143 (1996) 1257-1265
13. Comp P.C., Thurnau G.R., Welsh J., and Esmon C.T. Functional and immunologic protein S levels are decreased during pregnancy. Blood 68 (1986) 881-885
14. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
15. Danneberg J., Abbes A.P., Bruggeman B.J., Engel H., Gerrits J., and Martens A. Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin). Clin Chem 44 (1998) 349-351
16. Exner T., Triplett D.A., Taberner D., and Machin S.J. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 65 (1991) 320-322
17. Araki A., and Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422 (1987) 43-52
18. Den Heijer M., Koster T., Blom H.J., Bos G.M., Briet E., Reitsma P.H., et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334 (1996) 759-762
19. Martinelli I., Battaglioli T., Pedotti P., Cattaneo M., and Mannucci P.M. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 102 (2003) 1363-1366
20. Reuner K.H., Ruf A., Grau A., Rickmann H., Stolz E., Juttler E., et al. Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis. Stroke 29 (1998) 1765-1769
21. De Bruijn S.F.T.M., Stam J., Koopman M.M., and Vandenbroucke J.P. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ 316 (1998) 589-592
22. Martinelli I., Sacchi E., Landi G., Taioli E., Duca F., and Mannucci P.M. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 338 (1998) 1793-1797